COMPANY
Meitheal Pharmaceuticals, Inc
Meitheal Pharmaceuticals, Inc: US labeler, recalling firm for Cetrorelix, Daptomycin, Desmopressin, Ganirelix, Leuprolide, Liraglutide, Octreotide, Vancomycin, as stated by public registers.
Also written as: Meitheal Pharmaceuticals Inc.; Meitheal Pharmaceuticals, Inc.; Meitheal Pharmaceuticals Inc.
US LABELER
Lists a finished product with FDA (NDC directory); can be a maker, repackager or distributor.
| Cetrorelix | Cetrorelix Acetate, ANDA Regulator openFDA |
|---|---|
| Daptomycin | DAPTOMYCIN, ANDA Regulator openFDA |
| Desmopressin | Desmopressin acetate, ANDA Regulator openFDA |
| Ganirelix | Ganirelix Acetate, ANDA Regulator openFDA |
| Leuprolide | Leuprolide Acetate, ANDA Regulator openFDA |
| Liraglutide | Liraglutide, ANDA Regulator openFDA |
| Octreotide | Octreotide Acetate, ANDA Regulator openFDA |
| Vancomycin | Vancomycin hydrochloride, ANDA Regulator openFDA |
| Vancomycin | Vancomycin Hydrochloride, ANDA Regulator openFDA |
RECALLING FIRM
Recalled a product naming the peptide (FDA enforcement report).
| Cetrorelix | Class II recall, Ongoing, 2026-02-18 Regulator openFDA |
|---|
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.